Epilogue: Support devices for end stage heart failure

Cardiology Clinics

Volumn 21, Issue 1, 2003, Pages 135-139

  Jessup, Mariell ^a   Brozena, Susan C ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAUSE OF DEATH; HEART ASSIST DEVICE; HEART FAILURE; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0037910376     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8651(02)00139-X     Document Type: Review

References (33)

1. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL. Long-term mechanical left ventricular assistance for end-stage heart failure. Randomized evaluation of mechanical assistance for the treatment of congestive heart failure study. N Engl J Med 2001;345(20):1435-43.
2. Eichhorn EJ, Bristow MR. Medical therapy can improve the biological properties of the chronically failing heart: a new era in the treatment of heart failure. Circulation 1996;94(9):2285-96.
3. Greenberg B, Quinones MA, Koilpillai C, Limacher M, Shindler D, Benedict C, et al. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction: results of the SOLVD echocardiography substudy. Circulation 1995;91(10):2573-81.
4. Kaplon R, Lombardi P. Passive constraint and new shape-change devices for heart failure. Semin Thorac Cardiovasc Surg 2002;14(2):150-6.
5. Saxon LA, De Marco T, Schafer J, Chatterjee K, Kumar UN, Foster E. Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling. Circulation 2002;105(11):1304-10.
6. McCarthy III RE, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000;342(10):690-5.
7. Pisani B, Taylor DO, Mason JW. Inflammatory myocardial diseases and cardiomyopathies. Am J Med 1997;102(5):459-69.
8. Hoeper MM, Galie N, Simonneau G, Rubin LJ, New treatments for pulmonary arterial hypertension. Am J Respir Crit Care Med 2002;165(9):1209-16.
9. Newman JH. Treatment of primary pulmonary hypertension-the next generation. N Engl J Med 2002;346(12):933-5.
10. Mancini DM, Beniaminovitz A, Levin H, Catanese K, Flannery M, DiTullio M, et al. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation 1998;98:2383-9.
11. Bristow MR. Mechanisms of development of heart failure in the hypertensive patient. Cardiology 1999;92(Suppl 1):3-6, discussion 7-9, 20-1.
12. Cleland JG, Progression from hypertension to heart failure. Mechanisms and management. Cardiology 1999;92(Suppl 1):10-9, discussion 20-1.
13. Himmelmann A. Hypertension: an important precursor of heart failure. Blood Pressure 1999;8(5-6):253-60.
14. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med 1992;327:685-91.
15. Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 2001;357(9266):1385-90.
16. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Jacobs AK, Hiratzka LF, Russell RO, Smith Jr SC. American College of Cardiology/American Heart. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2001;38(7):2101-13.
17. Banerjee P, Banerjee T, Khand A, Clark A, Cleland JG. Diastolic heart failure: neglected or misdiagnosed? J Am Coll Cardiol 2002;39:138-41.
18. Vasan R, Levy D. Defining diastolic heart failure. A call for standardized diagnostic criteria. Circulation 2000;101:2118-21.
19. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: part II: causal mechanisms and treatment. Circulation 2002;105(12):1503-8.
20. Senni M, Redfield M. Heart failure with preserved systolic function. A different natural history? J Am Coll Cardiol 2001;38:1277-82.
21. Brickner ME, Hillis LD, Lange RA. Congenital heart disease in adults. First of two parts. N Engl J Med 2000;342(4):256-63.
22. Brickner ME, Hillis LD, Lange RA. Congenital heart disease in adults. Second of two parts. N Engl J Med 2000;342(5):334-42.
23. Frazier OH, Myers TJ, Jarvik RK, Westaby S, Pigott DW, Gregoric ID, Khan T, Tamez DW, Conger JL, Macris MP. Research and development of an implantable, axial-flow left ventricular assist device: the Jarvik 2000 Heart. Ann Thorac Surg 2001;71(Suppl 3):S125-32; S144-6.
24. Mancini D, Goldsmith R, Levin H, Beniaminovitz A, Rose E, Catanese K, et al. Comparison of exercise performance in patients with chronic severe heart failure versus left ventricular assist devices. Circulation 1998;98(12):1178-83.
25. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346(24):1845-53.
26. Kerwin W, Botvinick E, O'Connell W, Merrick S, DeMarco T, Chatterjee K, et al. Ventricular contraction abnormalities in dilated cardiomyopathy: effect of biventricular pacing to correct interventricular dyssynchrony. J Am Coll Cardiol 2000;35(5):1221-7.
27. Leclercq C, Kass DA. Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol 2002;39(2):194-201.
28. Stevenson WG, Stevenson LW. Prevention of sudden death in heart failure. J Cardiovasc Electrophysiol 2001;12(1):112-4.
29. Stevenson WG, Stevenson LW, Middlekauff HR, Fonarow GC, Hamilton MA, Woo MA, et al. Improving survival for patients with advanced heart failure: a study of 737 consecutive patients. J Am Coll Cardiol 1995;26(6):1417-23.
30. Alpert MA. Cardiovascular factors influencing survival in dialysis patients. Adv Perit Dial 1996;12:110-9.
31. Eggers PW, Frankenfield DL, Greer JW, McClellan W, Owen Jr WF, Rocco MV. Comparison of mortality and intermediate outcomes between medicare dialysis patients in HMO and fee for service. Am J Kidney Dis 2002;39(4):796-804.
32. Soucie JM, McClellan WM. Early death in dialysis patients: risk factors and impact on incidence and mortality rates. J Am Soc Nephrol 1996;7(10):2169-75.
33. Zoccali C. Cardiovascular risk in uraemic patients - is it fully explained by classical risk factors? Nephrol Dial Transplant 2000;15(4):454-7.